MELEXIS NV (MELE.BR) Forecast, Price Target & Analyst Ratings

EBR:MELEBE0165385973

Current stock price

68.65 EUR
+2.8 (+4.25%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MELEXIS NV (MELE.BR).

Forecast Snapshot

Consensus Price Target

Price Target
€63.91
-6.91% Downside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
€0.67
Revenue Estimate
206.74M

ChartMill Buy Consensus

Rating
76.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
€63.91
Upside
-6.91%
From current price of €68.65 to mean target of €63.91, Based on 20 analyst forecasts
Low
€48.48
Median
€66.30
High
€78.75

Price Target Revisions

1 Month
-0.61%
3 Months
-11.47%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for MELE.BR. The average price target is 63.91 EUR. This implies a price decrease of -6.91% is expected in the next year compared to the current price of 68.65.
The average price target has been revised downward by 11.47% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

MELE Current Analyst RatingMELE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

MELE Historical Analyst RatingsMELE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
76.00%
MELE.BR was analyzed by 20 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about MELE.BR.
In the previous month the buy percentage consensus was at a similar level.
MELE.BR was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-04-07JefferiesUpgrade Hold -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
€0.67
Revenue Estimate
206.74M
Revenue Q2Q
4.28%
EPS Q2Q
9.52%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
-2.50%
Revenue (3 Months)
-7.30%
EPS (1 Month)
-8.07%
EPS (3 Months)
-11.05%

Next Earnings Summary

MELE.BR is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 0.67 EUR and the consensus revenue estimate is 206.74M EUR.
The next earnings revenue estimate has been revised downward by 7.3% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MELE.BR revenue by date.MELE.BR revenue by date.
964.298M
15.32%
932.808M
-3.27%
839.617M
-9.99%
867.17M
3.28%
945.74M
9.06%
1.026B
8.49%
1.149B
11.99%
1.189B
3.48%
1.244B
4.63%
1.388B
11.58%
1.506B
8.50%
EBITDA
YoY % growth
MELE.BR ebitda by date.MELE.BR ebitda by date.
313.755M
13.30%
274.498M
-12.51%
187.302M
-31.77%
205.58M
9.76%
245.93M
19.63%
281.33M
14.39%
351.38M
24.90%
329.99M
-6.09%
285.76M
-13.40%
444.07M
55.40%
520.13M
17.13%
EBIT
YoY % growth
MELE.BR ebit by date.MELE.BR ebit by date.
268.586M
15.90%
226.757M
-15.57%
133.963M
-40.92%
155.77M
16.28%
193.72M
24.36%
224.15M
15.71%
272.21M
21.44%
276.76M
1.67%
295.24M
6.68%
344.54M
16.70%
373.66M
8.45%
Operating Margin
MELE.BR operating margin by date.MELE.BR operating margin by date.
27.85%24.31%15.96%17.96%20.48%21.85%23.69%23.28%23.73%24.82%24.81%
EPS
YoY % growth
MELE.BR eps by date.MELE.BR eps by date.
5.18
6.15%
4.23
-18.34%
2.79
-34.04%
3.01
8.00%
3.83
27.10%
4.51
17.66%
5.83
29.49%
5.38
-7.84%
4.52
-15.89%
7.51
66.14%
8.87
18.06%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.67
9.52%
0.83
-11.75%
1.00
46.77%
0.97
73.28%
0.91
36.18%
1.03
24.07%
1.14
14.15%
1.06
9.01%
Revenue
Q2Q % growth
206.74M
4.28%
222.91M
5.35%
237.28M
10.22%
240.61M
12.18%
225.85M
9.24%
240.53M
7.90%
250.15M
5.42%
253.1M
5.19%
EBITDA
Q2Q % growth
47.169M
14.33%
53.244M
-14.62%
60.131M
-23.01%
60.51M
-28.66%
56.387M
19.54%
62.967M
18.26%
68.955M
14.67%
64.763M
7.03%
EBIT
Q2Q % growth
34.618M
19.44%
41.12M
15.34%
47.95M
26.70%
48.136M
52.89%
45.321M
30.92%
51.182M
24.47%
56.698M
18.24%
52.362M
8.78%

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
17.33%
EPS Next 5 Year
14.02%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
6.08%
Revenue Next 5 Year
6.71%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
25.78%
EBIT Next 5 Year
18.48%

MELEXIS NV / MELE.BR Forecast FAQ

What is the price target for MELE stock?

20 analysts have analysed MELE.BR and the average price target is 63.91 EUR. This implies a price decrease of -6.91% is expected in the next year compared to the current price of 68.65.

When does MELEXIS NV (MELE.BR) report earnings?

MELEXIS NV (MELE.BR) will report earnings on 2026-04-29.

Can you provide the consensus estimates for MELEXIS NV next earnings?

The consensus EPS estimate for the next earnings of MELEXIS NV (MELE.BR) is 0.67 EUR and the consensus revenue estimate is 206.74M EUR.

What is the consensus rating for MELEXIS NV (MELE.BR) stock?

The consensus rating for MELEXIS NV (MELE.BR) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.